CGEM Cash & Short-Term Investments

Cullinan Therapeutics Inc · Cash & Short-Term Investments

CGEM logo

CGEM Cash & Short-Term Investments

Latest reported$377.90M
CGEM FY Cash & Short-Term Investments ($33.83M → $377.90M)
High-resolution chart · PNG

CGEM cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cullinan Therapeutics Inc Cash & Short-Term Investments — Annual fiscal periods (USD)
Period endingCash & Short-Term Investments (USD)
377,896,000
398,977,000
467,067,000
467,292,000
290,466,000
210,206,000
98,630,000
33,832,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.